DORA CARCOBA: Open Payments
NPI 1689815797 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,362 in 51 payments from 11 companies in 2025. Trend: 2023 $1,642 · 2024 $2,298 · 2025 $2,362
Food & beverage: $2,362
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $660 |
| AstraZeneca Pharmaceuticals LP | 11 | $516 |
| Abbott Laboratories | 8 | $435 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $220 |
| Boston Scientific Corporation | 1 | $136 |
| Dexcom, Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $107 |
| Exact Sciences Corporation | 5 | $87 |
| Lilly USA, LLC | 2 | $49 |
| Amgen Inc. | 1 | $16 |
Products named: Ozempic, BREZTRI, AIRSUPRA, Wegovy, Kerendia, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, WATCHMAN FLX, ESPRIT.
Industry payments across TX — which companies pay providers there.
